dobutamine has been researched along with Weight Reduction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdesselam, I; Borlaug, BA; Byrne, J; Lewis, AJM; Neubauer, S; Rayner, JJ; Rider, OJ | 1 |
| Hagström-Toft, E; Hellström, L; Reynisdottir, S; Rössner, S | 1 |
| Alméras, N; Després, JP; Imbeault, P; Lacaille, M; Langin, D; Mauriège, P; Tremblay, A | 1 |
3 other study(ies) available for dobutamine and Weight Reduction
| Article | Year |
|---|---|
Adverse right ventricular remodelling, function, and stress responses in obesity: insights from cardiovascular magnetic resonance.
Topics: Dobutamine; Humans; Magnetic Resonance Spectroscopy; Obesity; Obesity, Morbid; Stroke Volume; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Remodeling; Weight Loss | 2022 |
Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
Topics: Adenosine Deaminase; Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Biomarkers; Biopsy; Clonidine; Cohort Studies; Colforsin; Dobutamine; Dose-Response Relationship, Drug; Female; Glycerol; Humans; Isoproterenol; Lipolysis; Middle Aged; Norepinephrine; Obesity; Receptors, Adrenergic, alpha; Terbutaline; Time Factors; Weight Loss | 1997 |
Regional and gender variations in adipose tissue lipolysis in response to weight loss.
Topics: Adenosine Deaminase; Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Dobutamine; Epinephrine; Female; Humans; In Vitro Techniques; Isoproterenol; Lipolysis; Male; Middle Aged; Obesity; Procaterol; Radioligand Assay; Sex Characteristics; Tissue Distribution; Weight Loss | 1999 |